Cargando…
The Regulation of NFE2L2 (NRF2) Signalling and Epithelial-to-Mesenchymal Transition in Age-Related Macular Degeneration Pathology
Age-related macular degeneration (AMD) is a mounting cause of loss of sight in the elderly in the developed countries, a trend enhanced by the continual ageing of the population. AMD is a multifactorial and only partly understood, malady. Unfortunately, there is no effective treatment for most AMD p...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6888570/ https://www.ncbi.nlm.nih.gov/pubmed/31752195 http://dx.doi.org/10.3390/ijms20225800 |
_version_ | 1783475261436592128 |
---|---|
author | Hyttinen, Juha M. T. Kannan, Ram Felszeghy, Szabolcs Niittykoski, Minna Salminen, Antero Kaarniranta, Kai |
author_facet | Hyttinen, Juha M. T. Kannan, Ram Felszeghy, Szabolcs Niittykoski, Minna Salminen, Antero Kaarniranta, Kai |
author_sort | Hyttinen, Juha M. T. |
collection | PubMed |
description | Age-related macular degeneration (AMD) is a mounting cause of loss of sight in the elderly in the developed countries, a trend enhanced by the continual ageing of the population. AMD is a multifactorial and only partly understood, malady. Unfortunately, there is no effective treatment for most AMD patients. It is known that oxidative stress (OS) damages the retinal pigment epithelium (RPE) and contributes to the progression of AMD. We review here the potential importance of two OS-related cellular systems in relation to AMD. First, the nuclear factor erythroid 2-related factor 2 (NFE2L2; NRF2)-mediated OS response signalling pathway is important in the prevention of oxidative damage and a failure of this system could be critical in the development of AMD. Second, epithelial-to-mesenchymal transition (EMT) represents a change in the cellular phenotype, which ultimately leads to the fibrosis encountered in RPE, a characteristic of AMD. Many of the pathways triggering EMT are promoted by OS. The possible interconnections between these two signalling routes are discussed here. From a broader perspective, the control of NFE2L2 and EMT as ways of preventing OS-derived cellular damage could be potentially valuable in the therapy of AMD. |
format | Online Article Text |
id | pubmed-6888570 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-68885702019-12-09 The Regulation of NFE2L2 (NRF2) Signalling and Epithelial-to-Mesenchymal Transition in Age-Related Macular Degeneration Pathology Hyttinen, Juha M. T. Kannan, Ram Felszeghy, Szabolcs Niittykoski, Minna Salminen, Antero Kaarniranta, Kai Int J Mol Sci Review Age-related macular degeneration (AMD) is a mounting cause of loss of sight in the elderly in the developed countries, a trend enhanced by the continual ageing of the population. AMD is a multifactorial and only partly understood, malady. Unfortunately, there is no effective treatment for most AMD patients. It is known that oxidative stress (OS) damages the retinal pigment epithelium (RPE) and contributes to the progression of AMD. We review here the potential importance of two OS-related cellular systems in relation to AMD. First, the nuclear factor erythroid 2-related factor 2 (NFE2L2; NRF2)-mediated OS response signalling pathway is important in the prevention of oxidative damage and a failure of this system could be critical in the development of AMD. Second, epithelial-to-mesenchymal transition (EMT) represents a change in the cellular phenotype, which ultimately leads to the fibrosis encountered in RPE, a characteristic of AMD. Many of the pathways triggering EMT are promoted by OS. The possible interconnections between these two signalling routes are discussed here. From a broader perspective, the control of NFE2L2 and EMT as ways of preventing OS-derived cellular damage could be potentially valuable in the therapy of AMD. MDPI 2019-11-18 /pmc/articles/PMC6888570/ /pubmed/31752195 http://dx.doi.org/10.3390/ijms20225800 Text en © 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Hyttinen, Juha M. T. Kannan, Ram Felszeghy, Szabolcs Niittykoski, Minna Salminen, Antero Kaarniranta, Kai The Regulation of NFE2L2 (NRF2) Signalling and Epithelial-to-Mesenchymal Transition in Age-Related Macular Degeneration Pathology |
title | The Regulation of NFE2L2 (NRF2) Signalling and Epithelial-to-Mesenchymal Transition in Age-Related Macular Degeneration Pathology |
title_full | The Regulation of NFE2L2 (NRF2) Signalling and Epithelial-to-Mesenchymal Transition in Age-Related Macular Degeneration Pathology |
title_fullStr | The Regulation of NFE2L2 (NRF2) Signalling and Epithelial-to-Mesenchymal Transition in Age-Related Macular Degeneration Pathology |
title_full_unstemmed | The Regulation of NFE2L2 (NRF2) Signalling and Epithelial-to-Mesenchymal Transition in Age-Related Macular Degeneration Pathology |
title_short | The Regulation of NFE2L2 (NRF2) Signalling and Epithelial-to-Mesenchymal Transition in Age-Related Macular Degeneration Pathology |
title_sort | regulation of nfe2l2 (nrf2) signalling and epithelial-to-mesenchymal transition in age-related macular degeneration pathology |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6888570/ https://www.ncbi.nlm.nih.gov/pubmed/31752195 http://dx.doi.org/10.3390/ijms20225800 |
work_keys_str_mv | AT hyttinenjuhamt theregulationofnfe2l2nrf2signallingandepithelialtomesenchymaltransitioninagerelatedmaculardegenerationpathology AT kannanram theregulationofnfe2l2nrf2signallingandepithelialtomesenchymaltransitioninagerelatedmaculardegenerationpathology AT felszeghyszabolcs theregulationofnfe2l2nrf2signallingandepithelialtomesenchymaltransitioninagerelatedmaculardegenerationpathology AT niittykoskiminna theregulationofnfe2l2nrf2signallingandepithelialtomesenchymaltransitioninagerelatedmaculardegenerationpathology AT salminenantero theregulationofnfe2l2nrf2signallingandepithelialtomesenchymaltransitioninagerelatedmaculardegenerationpathology AT kaarnirantakai theregulationofnfe2l2nrf2signallingandepithelialtomesenchymaltransitioninagerelatedmaculardegenerationpathology AT hyttinenjuhamt regulationofnfe2l2nrf2signallingandepithelialtomesenchymaltransitioninagerelatedmaculardegenerationpathology AT kannanram regulationofnfe2l2nrf2signallingandepithelialtomesenchymaltransitioninagerelatedmaculardegenerationpathology AT felszeghyszabolcs regulationofnfe2l2nrf2signallingandepithelialtomesenchymaltransitioninagerelatedmaculardegenerationpathology AT niittykoskiminna regulationofnfe2l2nrf2signallingandepithelialtomesenchymaltransitioninagerelatedmaculardegenerationpathology AT salminenantero regulationofnfe2l2nrf2signallingandepithelialtomesenchymaltransitioninagerelatedmaculardegenerationpathology AT kaarnirantakai regulationofnfe2l2nrf2signallingandepithelialtomesenchymaltransitioninagerelatedmaculardegenerationpathology |